A Study to Evaluate the Safest Dose Range for FEIBA in Hemophilia A Patients With Inhibitors on Emicizumab
Clinical trial NCT04205175 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT04205175
- Sponsor
- Children's Hospital Los Angeles
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2020-07-01
- Primary completion
- 2022-10-01
- Enrollment
- 20
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.